Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection

Nephrology Dialysis Transplantation

Volumn 11, Issue 6, 1996, Pages 1096-1103

  Prodjosudjadi, W ^a   Daha, M R ^a   Gerritsma, J S J ^a   Florijn, K W ^a   Barendregt, J N M ^a   Bruijn, J A ^a   Van Der Woude, F J ^a   Van Es, L A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute rejection; MCP 1; Urinary excretion

Indexed keywords

CD14 ANTIGEN; CELL MARKER; CHEMOATTRACTANT; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; GEL FILTRATION CHROMATOGRAPHY; GRAFT REJECTION; HUMAN; IMMUNOPEROXIDASE STAINING; INTERSTITIUM; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TUBULE EPITHELIUM; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RADIOIMMUNOASSAY; URINARY EXCRETION;

EID: 0029995785     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.6.1096     Document Type: Article

References (38)

1. Ferguson R. Acute rejection episodes - Best predictor of long-term primary cadaveric renal transplant survival. Clin Transplant 1994; 8: 328-331
2. Johnson P, Chaharmohal A, Buchmann E, Roza AM, Adams MB. Plasma IL-2 levels and diagnosis of renal transplant rejection. Transplant Proc 1990; 22: 1849-1851
3. Albert FW, Schmidt U, Seyfert UT, Wurmell W, Gumbel W. Interleukin-2 measurement in pheripheral blood after kidney transplantation. Transplant Proc 1990; 22: 1852-1853
4. Forsythe JLR, Shenton BK. Plasma interleukin 2 receptor levels in renal allograft dysfunction. Transplantation 1989; 48: 155-157
5. Noronha IL, Daniel V, Rambausek M, Waldherr R, Opelz G. Soluble interleukin-2 receptor (sIL-2R) and tumor necrosis factor plasma levels in renal allograft recipients. Transplant Proc 1990; 22: 1859-1860
6. Dorge SE, Pascale RL, Dayer JM, Koch KM, Frei U, Lonnemann G. Plasma levels of tumor necrosis factor (TNF) and soluble TNF receptors in kidney transplant recipients. Transplantation 1994; 58: 1000-1008
7. Maury CPJ, Teppo AM. Serum immunoreactive interleukin I in renal transplant recipients. Transplantation 1988; 45: 143-147
8. Traindl O, Gisinger C, Reading S, Rosenkranz AR, Zlabinger GJ. Circulating serum levels of soluble CD23 (sCD23) after renal transplantation. Clin Transplant 1994; 8: 87-92
9. Steiner G, Zlabinger G, Karamehic J, Pohanka E, Kovarik J, Woloszczuk W. Interferon-gamma, neopterin, and interleukin-2 receptor levels in serum of kidney transplant recipients. Transplant Proc 1990; 22: 1857-1858
10. Ruggenenti P, Noris M, Casiragi F, Perico N, Benigni A, Remuzzi G. Urinary IL-6 but not serum IL-6 and urinary and serum soluble IL-2 receptor (IL-2R) predicts acute rejection in renal transplant recipients. J Am Soc Nephrol 1994; 5: 1035 (Abstr)
11. Bogman MJJT, Dooper IMM, van de Winkel JGJ et al. Diagnosis of renal allograft rejection by macrophage immunostaining with a CD14 monoclonal antibody, WT 14. Lancet 1989; 2: 235-238
12. Dooper INM, Hoitsma AJ, Maass CN et al. The extent of peritubular CD14 staining in renal allografts as an independent immunohistological marker for acute rejection. Transplantation 1994; 58: 820-827
13. Hancock WW, Thomson NM, Atkins RC. Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts. Transplantation 1983; 35: 458-463
14. Brady HR. Leukocyte adhesion molecules: potential targets for therapeutic intervention in kidney diseases. Curr Opin Nephrol Hypertens 1993; 2: 171-182
15. Bishop GA, Hall BM. Expression of leukocyte and lymphocyte adhesion molecules in human kidney. Kidney Int 1989; 36: 1078-1085
16. Schmouder RL, Kunkel SL. The cytokine response in renal allograft rejection. Nephrol Dial Transplant 1995; 10 [Suppl. 1]: 36-43
17. Rovin BH, Yoshiumura T, Tan L. Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol 1992; 148: 2148-2153
18. Sica A, Wang JM, Colota F et al. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J Immunol 1990; 144: 3034-3038
19. Yoshimura T, Leonard J. Secretion by human fibroblasts of monocyte chemoattractant protein-1, the product of gene JE. J Immunol 1990; 144: 2377-2383
20. Schmouder RL, Strieter RM, Kunkel SL. Interferon gamma regulation of human renal cortical epithelial cell-derived monocyte chemotactic peptide- 1. Kidney Int 1993; 44: 43-49
21. Akahoshi T, Wada C, Endo H et al. Expression of monocyte chemotactic and activating factor in rheumatoid arthritis. Arthritis Rheum 1993; 36: 762-771
22. Stahl RAK, Thaiss F, Disser M, Helmchen U, Hora K, Schlondorff D. Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 1993; 44: 1036-1047
23. Prodjosudjadi W, Gerritsma JSJ, Klar-Mohamad N et al. Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int 1995; 48: 1477-1486
24. Prodjosudjadi W, Gerritsma JSJ, van Es LA, Daha MR, Bruijn JA. Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis. Clin Nephrol 1995; 44: 148-155
25. Chantier C. Kidney disease in children. In: Schrier RW, Gottschalk CW, eds. Diseases of the Kidney. Little, Brown and Co., Boston, 1993; 2379-2403
26. Kooymans-Coutinho MF, Bruijn JA, Hermans J et al. Evaluation by histology, immunohistology and PCR of protocolized renal biopsies 1 week post-transplant in relation to subsequent rejection episodes. Nephrol Dial Transplant 1995; 10: 847-854
27. Yard BA, Kooymans-Coutinho, Reterink T et al. Analysis of T cell lines from rejecting renal allografts. Kidney Int 1993; 43 [Suppl 39]: S133-S138
28. Faull RF, Russ GR. Tubular expression of intercellular adhesion molecule-1 during allograft rejection. Transplantation 1989; 48: 226-230
29. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K, Properties of the novel proinflammatory supergene 'intercrine' cytokine family. Annu Rev Immunol 1991; 9: 617-648
30. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T-lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347: 669-671
31. Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1α and MIP-1β. Science 1993; 260: 355-357
32. Heeger P, Wolf G, Meyers C et al. Isolation and characterization of cDNA from renal tubular epithelium encoding murine RANTES. Kidney Int 1992; 41: 220-225
33. Pattison J, Nelson PJ, Huie P et al. RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet 1994; 343: 209-211
34. Andersen CB, Blaehr H, Hartley RB, Nolasco F, Cameron JS. Expression of intercellular adhesion molecule-1 in human renal allografts and culture human tubular cells. Nephrol Dial Transplant 1992; 7: 147-154
35. Briscoe DM, Pober JS, Harmon WE, Cotran RS. Expression of vascular cell adhesion molecule-1 (VCAM-1) in human renal allograft. J Am Soc Nephrol 1992; 3: 1180-1185
36. Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factors produced by a human myelomonocytic cell line. J Exp Med 1989; 169: 1485-1490
37. Jiang Y, Tabak LA, Valente AJ, Graves DT. Initial characterization the carbohydrate structure of MCP- 1. Biochem Biophys Res Comm 1991; 178: 1400-1404
38. Yoshimura T, Robinson EA, Tanaka S, Appella E, Leonard EJ. Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. J Immunol 1989;142: 1956-1962